Haram Annbjørg, Fosse Roar, Jonsbu Egil, Hole Torstein
Department of Psychiatry, Møre and Romsdal Hospital Trust, Ålesund, Norway.
Division of Mental Health and Addiction, Vestre Viken Hospital Trust, Drammen, Norway.
Front Psychiatry. 2019 Apr 11;10:204. doi: 10.3389/fpsyt.2019.00204. eCollection 2019.
The need for psychological therapies for psychosis has become apparent since long-term antipsychotic drug treatment has a range of adverse side effects, with moderate therapeutic effects at best. To investigate whether the psychotherapeutic approach, dialogue therapy (DT) is associated with improvements of symptoms and functioning beyond standard psychiatric treatment (ST) in both schizophrenia and other psychosis. A retrospective case-control design, comparing 54 patients with different psychoses who received DT with 54 patients in a control group receiving ST was carried out. The groups were matched on diagnosis, age, sex, and treatment start. Outcome measures were Global assessment of functioning (GAF) scores, medications at follow up, and hospital stays after completed outpatient treatment. Mean time in treatment from inclusion to follow-up was 3 years and 5 months. At follow-up, GAF functioning (GAF-F) and GAF symptom (GAF-S) scores both were significantly higher in the DT group than the ST group. Effect sizes (Cohen's d) were large; 1.8 for GAF-S and 2.1 for GAF-F. At follow-up, the use of psychoactive drugs was significantly reduced despite a shorter time in psychotherapy in the DT group compared to the ST group. Days of hospitalizations after end of treatment in the study period were significantly reduced in both groups compared to the period before start of treatment. The findings from this exploratory study are consistent with the possibility that dialogue therapy may lead to improvements in symptoms and functioning compared to standard treatment in psychosis.
由于长期使用抗精神病药物治疗存在一系列不良副作用,且治疗效果至多为中等,因此对精神病进行心理治疗的需求已变得显而易见。为了研究心理治疗方法——对话疗法(DT)是否与精神分裂症和其他精神病患者在标准精神病治疗(ST)基础上的症状改善和功能提升相关。进行了一项回顾性病例对照设计,将54例接受DT治疗的不同精神病患者与54例接受ST治疗的对照组患者进行比较。两组在诊断、年龄、性别和治疗开始时间方面进行了匹配。结果测量指标包括功能总体评估(GAF)得分、随访时的用药情况以及完成门诊治疗后的住院天数。从纳入研究到随访的平均治疗时间为3年零5个月。在随访时,DT组的GAF功能(GAF-F)和GAF症状(GAF-S)得分均显著高于ST组。效应量(科恩d值)较大;GAF-S为1.8,GAF-F为2.1。在随访时,尽管DT组的心理治疗时间比ST组短,但精神活性药物的使用显著减少。与治疗开始前的时期相比,研究期间两组治疗结束后的住院天数均显著减少。这项探索性研究的结果与以下可能性一致,即与精神病的标准治疗相比对话疗法可能会导致症状改善和功能提升。